Clinical Trial Update: Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing vildagliptin with glibenclamide to assess endothelial function in patients with type 2 diabetes and hypertension has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Glibenclamide (glibenclamide)
• Vildagliptin (vildagliptin)

Snippet

Sponsor: Dr. José Fernando Vilela-Martin MD PhD | Conditions: Type 2 Diabetes Mellitus, Hypertension | Phase 4 | Status: COMPLETED